CALR (Calreticulin) variants and mutations

CALR (also known as Calreticulin) is a human protein-coding gene encoding a calreticulin protein. It assists glycoprotein folding and buffers calcium within the endoplasmic reticulum. Somatic frameshift variants create abnormal C termini that activate thrombopoietin-receptor signaling and are major drivers of essential thrombocythemia and primary myelofibrosis. This analysis covers 620 CALR variants and mutations. Of these, 78% have computational variant effect predictions. Disease context includes neoplasm, myeloproliferative disorder, and thrombocythemia 1. Example CALR variants include L2V, L3R, and L3I.

Variant analysis overview

Variant and mutation evidence

Clinical, disease, and population context

Protein structure and variant hotspots

Data sources

Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.

Notable CALR variants

Examples include L2V, L3R, L3I, L3L, S4P, S4S, V5G, V5M. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.